This study is a non-drug follow up study to A3051123 for cardiac assessments after use of smoking cessation treatments

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005513-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the CV safety assessment will be to characterize the cardiovascular safety profiles of varenicline and bupropion compared to placebo.


Critère d'inclusion

  • Nicotine Addiction with the desire to quit smoking